Literature DB >> 744057

Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion.

G S Tannenbaum, J Epelbaum, E Colle, P Brazeau, J B Martin.   

Abstract

The role of SRIF in starvation-induced inhibition of GH and insulin secretion was assessed by passive immunization with anti-SRIF serum. Six-hour secretory profiles obtained from chronically cannulated male rats deprived of food for 72 h showed marked suppression of GH secretory bursts and significant depression of plasma insulin levels. Administration of 1 ml SRIF antiserum (SRIF AS) iv to starved rats resulted in rapid (within 15 min) restoration of high amplitude GH pulses (600-800 ng/ml) and sighificant elevation of GH trough values. The mean 6-h GH level of starved SRIF, AS-treated rats (189.2 +/- 23.9 ng/ml) was significantly higher than that of starved, normal sheep serum-treated control animals (62.8 +/- 5.8 ng/ml) (P less than 0.005). In contrast to the effects on GH, plasma insulin levels in starved rats administered SRIF AS remained low. No significant difference was observed in the mean 6-h plasma insulin level of starved-SRIF, AS-treated rats when compared to starved, normal sheep serum-treated controls. These findings suggest that circulating SRIF is a physiological regulator of starvation-induced GH suppression but is not involved in mediating the inhibition of insulin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 744057     DOI: 10.1210/endo-102-6-1909

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Growth hormone-releasing hormone and growth hormone secretagogue-receptor ligands: focus on reproductive system.

Authors:  E Arvat; L Gianotti; R Giordano; F Broglio; M Maccario; F Lanfranco; G Muccioli; M Papotti; A Graziani; E Ghigo; R Deghenghi
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

2.  Hypothalamic control of GH secretion: pathophysiology and clinical implications.

Authors:  H J Quabbe
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

Review 3.  Regulation of growth hormone secretion in man: a review.

Authors:  D G Johnston; R R Davies; R W Prescott
Journal:  J R Soc Med       Date:  1985-04       Impact factor: 5.344

4.  Adrenal involvement in the diabetes-induced loss of growth hormone and prolactin receptors in the livers of female rats.

Authors:  J M Bryson; R C Baxter
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

5.  Somatostatin is essential for the sexual dimorphism of GH secretion, corticosteroid-binding globulin production, and corticosterone levels in mice.

Authors:  Jessica M Adams; Veronica Otero-Corchon; Geoffrey L Hammond; Johannes D Veldhuis; Nathan Qi; Malcolm J Low
Journal:  Endocrinology       Date:  2014-12-31       Impact factor: 4.736

6.  Endogenous somatostatin-28 modulates postprandial insulin secretion. Immunoneutralization studies in baboons.

Authors:  J W Ensinck; R E Vogel; E C Laschansky; D J Koerker; R L Prigeon; S E Kahn; D A D'Alessio
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Release of somatostatin-like immunoreactivity from incubated rat hypothalamus and cerebral cortex. Effects of glucose and glucoregulatory hormones.

Authors:  M Berelowitz; D Dudlak; L A Frohman
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

Review 8.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  Effects of starvation on pituitary and plasma growth hormone in rats.

Authors:  C Gonzalez; T Jolin
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

10.  Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents.

Authors:  Jose Córdoba-Chacón; Manuel D Gahete; Mario Duran-Prado; Ana I Pozo-Salas; María M Malagón; F Gracia-Navarro; Rhonda D Kineman; Raul M Luque; Justo P Castaño
Journal:  Cell Mol Life Sci       Date:  2010-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.